Arenobufagin suppresses the progression of early-stage hepatocellular carcinoma by inhibiting EpCAM-mediated tumor stemness

Arenobufagin suppresses the progression of early-stage hepatocellular carcinoma by inhibiting EpCAM-mediated tumor stemness

Epithelial cell adhesion molecule (EpCAM) is a biomarker for epithelial cell-derived tumors. However, the specific role of EpCAM itself in early-stage hepatocellular carcinoma progression remains unclear, and small molecules targeting EpCAM have not yet been reported. Here, the protein expression pr...

Full description

Saved in:

Bibliographic Details
Main Authors:	Lijuan Deng, Lifang Zou, Chunhong Zhou, Fuqin Yang, Fen Ouyang, Yingru Zhu, Huihui Cao, Min Hu, Xiaoshen Zhang, Junshan Liu
Format:	Article
Language:	English
Published:	Compuscript Ltd 2025-01-01
Series:	Acta Materia Medica
Online Access:	https://www.scienceopen.com/hosted-document?doi=10.15212/AMM-2024-0064
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Biological roles and clinical applications of EpCAM in HCC
by: Peng Liu, et al.
Published: (2025-03-01)

Characteristics of stem sings of EpCAM-negative and EpCAM-positive tumor cells in primary tumor and 2D and 3D cultures in breast cancer
by: V. V. Alifanov, et al.
Published: (2024-11-01)

Construction, Expression, and Characterization of a Recombinant Immunotoxin Targeting EpCAM
by: Minghua Lv, et al.
Published: (2015-01-01)

EpCAM-Independent Enrichment of Circulating Tumor Cells in Metastatic Breast Cancer.
by: Helen Schneck, et al.
Published: (2015-01-01)

Targeting CD44 and EpCAM with Antibody Dye Conjugates for the Photoimmunotherapy of Prostate Cancer
by: Isis Wolf, et al.
Published: (2025-01-01)

EpCAM-targeted near-infrared photoimmunotherapy (NIR-PIT) for the treatment of breast cancer
by: Aki Furusawa, et al.
Published: (2025-12-01)

In Silico Design of Novel EpCAM-Binding Aptamers for Targeted Delivery of RNA Therapeutics
by: Julia Driscoll, et al.
Published: (2024-10-01)

Absence of EpCAM in cervical cancer cells is involved in slug induced epithelial-mesenchymal transition
by: Xian Liu, et al.
Published: (2021-03-01)

Landscape of cancer associated EpCAM mutations: molecular modeling, predictive insights and impact on patient survival
by: Priyanka S. Dhotare, et al.
Published: (2025-07-01)

Integrated cytomembrane proteomics identifies EpCAM/MGST1 as therapeutic targets in metastatic laryngeal carcinoma
by: Suling Zhuang, et al.
Published: (2025-07-01)

Transcriptional Read-Through Induction Treatment Trial in Intestinal Failure Induced by an EpCAM Nonsense Mutation
by: Mamata Sivagnanam, et al.
Published: (2012-01-01)

Prognostic significance of atypical/hybrid forms of EpCAM+CD45+ cells in the blood of patients with endometrial cancer
by: E. V. Kaigorodova, et al.
Published: (2023-08-01)

Combination Therapy with EpCAM-CAR-NK-92 Cells and Regorafenib against Human Colorectal Cancer Models
by: Qing Zhang, et al.
Published: (2018-01-01)

Selection of the optimal chelator for labeling of DARPin Ec1 with gallium-68 for PET imaging of EpCAM expression
by: Anzhelika Vorobyeva, et al.
Published: (2025-05-01)

Heterogeneity of EpCAM-positive cells in low-grade serous ovarian carcinoma ascitic fluid: a clinical case
by: E. V. Kaigorodova, et al.
Published: (2022-01-01)

Development of a bispecific antibody–drug conjugate targeting EpCAM and CLDN3 for the treatment of multiple solid tumors
by: Meiying Luo, et al.
Published: (2025-03-01)

Corrigendum to “Combination Therapy with EpCAM-CAR-NK-92 Cells and Regorafenib against Human Colorectal Cancer Models”
by: Qing Zhang, et al.
Published: (2019-01-01)

The epithelial cell adhesion molecule EpCAM is required for epithelial morphogenesis and integrity during zebrafish epiboly and skin development.
by: Krasimir Slanchev, et al.
Published: (2009-07-01)

A LncRNA panel within EpCAM-specific exosomes for noninvasive early diagnosing non-small cell lung cancer
by: Linyuan Liu, et al.
Published: (2025-04-01)

NAG-1/GDF15 as a tumor suppressor in colorectal cancer: inhibition of β-catenin and NF-κB pathways via interaction with EpCAM
by: Jaehak Lee, et al.
Published: (2025-05-01)

EpCAM-high liver cancer stem cells resist natural killer cell–mediated cytotoxicity by upregulating CEACAM1
by: Pil Soo Sung, et al.
Published: (2020-05-01)

Relationship between epithelial cell adhesion molecule (EpCAM) overexpression and gastric cancer patients: A systematic review and meta-analysis.
by: Meng Dai, et al.
Published: (2017-01-01)

Correlation between EpCAM expression and cervical lymph node metastasis in papillary thyroid carcinoma: a study integrating ultrasonographic features
by: Xia Zhang, et al.
Published: (2025-04-01)

Novel human single-domain antibodies exert potent anti-tumor activity by targeting EGF-like repeat epitope of EpCAM
by: Xiaofeng Zhou, et al.
Published: (2025-02-01)

EpCAM deficiency causes the premature ageing of intestinal stem cells via EGFR/SP1/mTORC1 pathway
by: Keying Li, et al.
Published: (2025-02-01)

A novel conditional active biologic anti-EpCAM x anti-CD3 bispecific antibody with synergistic tumor selectivity for cancer immunotherapy
by: Gerhard Frey, et al.
Published: (2024-12-01)

Diagnostic performance of circulating EpCAM+ and CD45+ extracellular vesicles in platinum-sensitivity in high-grade serous ovarian cancer: a pilot study
by: Chiara Tersigni, et al.
Published: (2025-05-01)

Silencing LY6K Suppresses CD44<sup>+</sup> EpCAM<sup>+</sup> HCT116 Human Colon Cancer Stem Cells Growth: Insights from In Vitro and In Vivo Evidence
by: Changhao Fu, et al.
Published: (2024-12-01)

Cellular and molecular mechanisms of arenobufagin in cancer therapy: a systematic review
by: Si-Jun Wang, et al.
Published: (2025-07-01)

MOF-derived intelligent arenobufagin nanocomposites with glucose metabolism inhibition for enhanced bioenergetic therapy and integrated photothermal-chemodynamic-chemotherapy
by: Lihua Chen, et al.
Published: (2025-01-01)

Germline variants of the MMR/EPCAM genes in Russian patients with Lynch syndrome
by: Aleksey S. Tsukanov, et al.
Published: (2024-09-01)

CD44 and EPCAM expression in pleomorphic adenoma and mucoepidermoid carcinoma: An immunohistochemical method
by: Laleh Maleki, et al.
Published: (2025-01-01)

Luteoloside suppresses proliferation and metastasis of hepatocellular carcinoma cells by inhibition of NLRP3 inflammasome.
by: Shao-hua Fan, et al.
Published: (2014-01-01)

Andrographolide suppresses cervical cancer progression by targeting angiogenesis and inducing apoptosis in a CAM-PDX model
by: Wanwan Zou, et al.
Published: (2025-02-01)

Targeting enabled homolog with daunorubicin inhibits ERK1/2/c‐Fos pathway and suppresses hepatocellular carcinoma progression
by: Zhi‐Mei Li, et al.
Published: (2025-06-01)

STEAP4 inhibits cisplatin-induced chemotherapy resistance through suppressing PI3K/AKT in hepatocellular carcinoma
by: Binhui Xie, et al.
Published: (2023-12-01)

L-741626 inhibits hepatocellular carcinoma progression by targeting Ref-1 to suppress MAPK/ERK signalling pathway activity
by: Shuiling Jin, et al.
Published: (2025-04-01)

Harnessing Lactiplantibacillus plantarum EP21 and its membrane vesicles to inhibit myopia development
by: Chi-Fong Lin, et al.
Published: (2025-12-01)

EPS inhibitor treatment of Salmonella impacts evolution without selecting for resistance to biofilm inhibition
by: Mathieu Joos, et al.
Published: (2025-05-01)

Flavonoid GL-V9 suppresses development of human hepatocellular cancer cells by inhibiting Wnt/β-Cantenin signaling pathway
by: Ye Gu, et al.
Published: (2025-04-01)